Search hospitals > South Carolina > Myrtle Beach
Carolina Urologic Research Center
Claim this profileMyrtle Beach, South Carolina 29572
Global Leader in Prostate Cancer
Global Leader in Bladder Cancer
Conducts research for Thyroid Cancer
Conducts research for Transitional Cell Carcinoma
Conducts research for Uterine Tumors
158 reported clinical trials
3 medical researchers
Summary
Carolina Urologic Research Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Bladder Cancer, Thyroid Cancer, Transitional Cell Carcinoma, Uterine Tumors and other specialties. Carolina Urologic Research Center is involved with conducting 158 clinical trials across 87 conditions. There are 3 research doctors associated with this hospital, such as Neal Shore, Abhishek Srivastava, MD, and Robert Jansen, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
Stage I
Stage II
2Bladder Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
Top PIs
Neal ShoreCarolina Urologic Research Center5 years of reported clinical research
Expert in Prostate Cancer
Expert in Bladder Cancer
36 reported clinical trials
53 drugs studied
Abhishek Srivastava, MDCarolina Urologic Research Center1 year of reported clinical research
Studies Bladder Cancer
Studies Thyroid Cancer
2 reported clinical trials
2 drugs studied
Robert Jansen, MDCarolina Urologic Research Center3 years of reported clinical research
Studies Prostate Cancer
1 reported clinical trial
2 drugs studied
Clinical Trials running at Carolina Urologic Research Center
Bladder Cancer
Prostate Cancer
Transitional Cell Carcinoma
Thyroid Cancer
Urothelial Carcinoma
Vulval Intraepithelial Neoplasia
Follicular Lymphoma
Lung Cancer
Uterine Tumors
Relapse
UGN-103
for Bladder Cancer
This Phase 3, single-arm, multicenter study will evaluate the efficacy and safety of UGN-103, a novel formulation of UGN-102, instilled in the urinary bladder of patients with low-grade non-muscle invasive bladder cancer (LG-NMIBC).
Recruiting2 awards Phase 32 criteria
TAR-200 vs Chemotherapy
for Bladder Cancer
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radical Cystectomy (RC), receiving TAR-200 versus investigator's choice of single agent intravesical chemotherapy.
Recruiting2 awards Phase 32 criteria
TAR-210
for Bladder Cancer
The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Carolina Urologic Research Center?
Carolina Urologic Research Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Bladder Cancer, Thyroid Cancer, Transitional Cell Carcinoma, Uterine Tumors and other specialties. Carolina Urologic Research Center is involved with conducting 158 clinical trials across 87 conditions. There are 3 research doctors associated with this hospital, such as Neal Shore, Abhishek Srivastava, MD, and Robert Jansen, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.